易方达标普生物科技指数证券投资基金(LOF)美元(003720)

管理费: 0.800% 托管费: 0.250%
最高认购费率: 1.000% 最低认购金额: 100.00元
状态: --  --

单位净值:

0.1690

累计净值:0.1690 净值更新日期:2020-04-07 基金类型:QDII
基金经理:范冰,刘树荣 管理人:易方达基金管理有限公司 投资类型:股票型
最新规模:0.536亿份(2020-03-31) 托管行:中国建设银行股份有限公司 成立日期:2016-12-13

业绩比较基准: 标普生物科技精选行业指数收益率(使用估值汇率折算)×95%+活期存款利率(税后)×5%

十大重仓股

  • 2019年
  • 2018年
  • 2017年
2019年4季度
序号 股票代码 股票名称 数量(股) 公允价值(元) 占基金资产净值比例(%)
1 MRTX US Mirati Therapeutics Inc 1,531 1,376,297.25 1.81
2 EXAS US Exact Sciences Corp 1,971 1,271,608.34 1.67
3 BMRN US BioMarin Pharmaceutical Inc 2,144 1,264,612.05 1.66
4 ICPT US Intercept Pharmaceuticals Inc 1,439 1,244,002.12 1.64
5 GBT US Global Blood Therapeutics Inc 2,235 1,239,392.74 1.63
6 AMGN US Amgen Inc 726 1,220,952.34 1.61
7 MDCO US The Medicines Company 2,041 1,209,411.75 1.59
8 ABBV US AbbVie Inc 1,956 1,208,167.90 1.59
9 BIIB US Biogen Inc 579 1,198,557.69 1.58
10 SGEN US Seattle Genetics Inc 1,509 1,202,824.82 1.58
2019年3季度
序号 股票代码 股票名称 数量(股) 公允价值(元) 占基金资产净值比例(%)
1 SGEN US Seattle Genetics Inc 2,147 1,296,843.09 2.00
2 ABBV US AbbVie Inc 2,151 1,151,989.53 1.77
3 MDCO US The Medicines Company 3,177 1,123,530.17 1.73
4 LGND US Ligand Pharmaceuticals Inc 1,556 1,095,480.74 1.69
5 CELG US Celgene Corp 1,541 1,082,304.35 1.67
6 AMGN US Amgen Inc 777 1,063,461.93 1.64
7 BIIB US Biogen Inc 641 1,055,542.76 1.63
8 REGN US Regeneron Pharmaceuticals Inc 538 1,055,568.08 1.63
9 UTHR US United Therapeutics Corp 1,879 1,059,875.83 1.63
10 INCY US Incyte Corp 1,984 1,041,642.39 1.60
2019年2季度
序号 股票代码 股票名称 数量(股) 公允价值(元) 占基金资产净值比例(%)
1 ARRY US Array BioPharma Inc 7,211 2,296,738.48 1.96
2 SRPT US Sarepta Therapeutics Inc 1,785 1,864,630.04 1.59
3 NVTA US Invitae Corp 11,096 1,792,619.27 1.53
4 GHDX US Genomic Health Inc 4,173 1,668,788.12 1.43
5 IMMU US Immunomedics Inc 17,263 1,646,063.11 1.41
6 FGEN US FibroGen Inc 5,245 1,629,091.47 1.39
7 RARE US Ultragenyx Pharmaceutical Inc 3,733 1,629,616.70 1.39
8 ALXN US Alexion Pharmaceuticals Inc 1,810 1,629,811.25 1.39
9 FOLD US Amicus Therapeutics Inc 18,799 1,612,883.82 1.38
10 CLVS US Clovis Oncology Inc 15,842 1,619,476.79 1.38
2019年1季度
序号 股票代码 股票名称 数量(股) 公允价值(元) 占基金资产净值比例(%)
1 LGND US Ligand Pharmaceuticals Inc 2,427 2,054,378.53 1.69
2 IMMU US Immunomedics Inc 15,724 2,033,907.81 1.67
3 IONS US Ionis Pharmaceuticals Inc 3,648 1,993,844.30 1.64
4 NBIX US Neurocrine Biosciences Inc 3,344 1,983,732.19 1.63
5 BLUE US Bluebird Bio Inc 1,851 1,960,915.26 1.61
6 ALNY US Alnylam Pharmaceuticals Inc 3,087 1,942,481.09 1.60
7 CELG US Celgene Corp 3,043 1,933,030.42 1.59
8 ARRY US Array BioPharma Inc 11,782 1,934,165.28 1.59
9 ICPT US Intercept Pharmaceuticals Inc 2,547 1,918,424.11 1.58
10 PTLA US Portola Pharmaceuticals Inc 7,999 1,868,985.95 1.54
2018年4季度
序号 股票代码 股票名称 数量(股) 公允价值(元) 占基金资产净值比例(%)
1 ABBV US AbbVie Inc 2,769 1,751,997.27 1.45
2 FGEN US FibroGen Inc 5,413 1,719,325.21 1.42
3 HRTX US Heron Therapeutics Inc 9,492 1,689,874.12 1.39
4 IONS US Ionis Pharmaceuticals Inc 4,478 1,661,448.12 1.37
5 MDGL US Madrigal Pharmaceuticals Inc 2,150 1,663,282.79 1.37
6 PTCT US PTC Therapeutics Inc 7,048 1,660,121.33 1.37
7 AMGN US Amgen Inc 1,234 1,648,696.98 1.36
8 TSRO US TESARO Inc 3,217 1,639,359.39 1.35
9 LOXO US Loxo Oncology Inc 1,707 1,640,987.62 1.35
10 UTHR US United Therapeutics Corp 2,197 1,642,043.25 1.35
2018年3季度
序号 股票代码 股票名称 数量(股) 公允价值(元) 占基金资产净值比例(%)
1 ACAD US ACADIA Pharmaceuticals Inc 21,175 3,024,048.17 1.76
2 VKTX US Viking Therapeutics Inc 22,851 2,738,364.76 1.59
3 ALXN US Alexion Pharmaceuticals Inc 2,487 2,378,262.37 1.38
4 SGMO US Sangamo Therapeutics Inc 19,792 2,307,795.49 1.34
5 IONS US Ionis Pharmaceuticals Inc 6,390 2,267,358.18 1.32
6 TSRO US TESARO Inc 8,416 2,258,497.49 1.31
7 ANAB US AnaptysBio Inc 3,242 2,225,107.10 1.29
8 ARRY US Array BioPharma Inc 21,221 2,218,949.25 1.29
9 LGND US Ligand Pharmaceuticals Inc 1,154 2,179,065.44 1.27
10 VRTX US Vertex Pharmaceuticals Inc 1,642 2,177,122.89 1.27
2018年2季度
序号 股票代码 股票名称 数量(股) 公允价值(元) 占基金资产净值比例(%)
1 SRPT US Sarepta Therapeutics Inc 1,838 1,607,482.06 1.61
2 HRTX US Heron Therapeutics Inc 5,883 1,512,254.04 1.52
3 PBYI US Puma Biotechnology Inc 3,707 1,450,815.60 1.45
4 FMI US Foundation Medicine Inc 1,503 1,359,447.30 1.36
5 VRTX US Vertex Pharmaceuticals Inc 1,191 1,339,347.79 1.34
6 REGN US Regeneron Pharmaceuticals Inc 582 1,328,508.61 1.33
7 EXEL US Exelixis Inc 9,245 1,316,388.45 1.32
8 ICPT US Intercept Pharmaceuticals Inc 2,354 1,306,938.22 1.31
9 ONCE US Spark Therapeutics Inc 2,292 1,255,075.86 1.26
10 LGND US Ligand Pharmaceuticals Inc 912 1,250,134.05 1.25
2018年1季度
序号 股票代码 股票名称 数量(股) 公允价值(元) 占基金资产净值比例(%)
1 ONCE US Spark Therapeutics Inc 3,086 1,292,184.05 1.49
2 RDUS US Radius Health Inc 5,388 1,217,657.36 1.40
3 FOLD US Amicus Therapeutics Inc 12,749 1,205,711.48 1.39
4 REGN US Regeneron Pharmaceuticals Inc 556 1,203,945.78 1.38
5 SRPT US Sarepta Therapeutics Inc 2,557 1,191,268.79 1.37
6 ALKS US Alkermes PLC 3,250 1,184,489.40 1.36
7 AGIO US Agios Pharmaceuticals Inc 2,265 1,164,755.45 1.34
8 UTHR US United Therapeutics Corp 1,647 1,163,656.42 1.34
9 BMRN US BioMarin Pharmaceutical Inc 2,268 1,156,172.57 1.33
10 CELG US Celgene Corp 2,053 1,151,653.76 1.32
2017年4季度
序号 股票代码 股票名称 数量(股) 公允价值(元) 占基金资产净值比例(%)
1 ARRY US Array BioPharma Inc 14,887 1,245,115.33 1.58
2 IMMU US Immunomedics Inc 11,822 1,248,316.57 1.58
3 EXEL US Exelixis Inc 6,178 1,227,195.94 1.56
4 CLVS US Clovis Oncology Inc 2,695 1,197,457.49 1.52
5 UTHR US United Therapeutics Corp 1,230 1,189,083.91 1.51
6 BMRN US BioMarin Pharmaceutical Inc 2,043 1,190,363.38 1.51
7 FOLD US Amicus Therapeutics Inc 12,622 1,186,810.54 1.50
8 AVXS US Avexis Inc 1,623 1,173,656.08 1.49
9 MDXG US MiMedx Group Inc 14,253 1,174,393.92 1.49
10 NBIX US Neurocrine Biosciences Inc 2,271 1,151,371.06 1.46
2017年3季度
序号 股票代码 股票名称 数量(股) 公允价值(元) 占基金资产净值比例(%)
1 ALNY US Alnylam Pharmaceuticals Inc 2,666 2,078,865.17 2.65
2 CLVS US Clovis Oncology Inc 2,926 1,600,172.52 2.04
3 PBYI US Puma Biotechnology Inc 1,884 1,497,344.37 1.91
4 EXAS US Exact Sciences Corp 4,628 1,447,317.81 1.84
5 BLUE US Bluebird Bio Inc 1,575 1,435,735.69 1.83
6 JUNO US Juno Therapeutics Inc 4,696 1,398,146.34 1.78
7 TSRO US TESARO Inc 1,633 1,399,193.25 1.78
8 NBIX US Neurocrine Biosciences Inc 3,404 1,384,438.23 1.76
9 SRPT US Sarepta Therapeutics Inc 4,569 1,375,496.46 1.75
10 AVXS US Avexis Inc 2,116 1,358,445.21 1.73
2017年2季度
序号 股票代码 股票名称 数量(股) 公允价值(元) 占基金资产净值比例(%)
1 CLVS US Clovis Oncology Inc 3,133 1,987,221.40 2.86
2 EXEL US Exelixis Inc 9,835 1,641,003.90 2.36
3 KITE US Kite Pharma Inc 2,156 1,514,163.22 2.18
4 ALXN US Alexion Pharmaceuticals Inc 1,796 1,480,337.28 2.13
5 CELG US Celgene Corp 1,601 1,408,545.92 2.03
6 GILD US Gilead Sciences Inc 2,926 1,402,993.69 2.02
7 ALNY US Alnylam Pharmaceuticals Inc 2,599 1,404,307.65 2.02
8 SRPT US Sarepta Therapeutics Inc 6,016 1,373,843.98 1.98
9 INCY US Incyte Corp 1,590 1,356,213.88 1.95
10 EXAS US Exact Sciences Corp 5,663 1,356,914.42 1.95
2017年1季度
序号 股票代码 股票名称 数量(股) 公允价值(元) 占基金资产净值比例(%)
1 VRTX US Vertex Pharmaceuticals Inc 9,588 7,233,555.91 2.61
2 BIVV US Bioverativ Inc 17,003 6,388,637.13 2.30
3 BLUE US Bluebird Bio Inc 10,176 6,381,841.46 2.30
4 CLVS US Clovis Oncology Inc 14,440 6,343,180.54 2.29
5 CELG US Celgene Corp 7,266 6,237,714.95 2.25
6 EXEL US Exelixis Inc 41,638 6,225,207.07 2.24
7 GILD US Gilead Sciences Inc 13,213 6,191,617.83 2.23
8 REGN US Regeneron Pharmaceuticals Inc 2,320 6,202,630.76 2.23
9 ABBV US AbbVie Inc 13,676 6,148,160.51 2.21
10 IONS US Ionis Pharmaceuticals Inc 21,535 5,972,772.31 2.15

合作电话:0755-83990201、83256219  Email:service@p5w.net

全景网络:获准从事登载财经类新闻业务 获准经营因特网信息服务业务

Copyright © 2000-2020 Panorama Network Co., Ltd, All Rights Reserved

全景网络有限公司版权所有

未经全景网书面授权,请勿转载内容或建立镜像,违者依法必究!

经营许可证号 粤B2-20050249
信息网络传播视听节目许可证
许可证号:1903034